Subtelomeric demethylation deregulated hTERT expression, telomerase activity, and telomere length in four nasopharyngeal carcinoma cell lines

Cancer Biotherapy and Radiopharmaceuticals

Volumn 29, Issue 7, 2014, Pages 289-294

  Zhang, Zi Xiong ^a   Wang, Yan ^a   Tao, Ze Zhang ^a   Chen, Shi Ming ^a   Xiao, Bo Kui ^a   Zhou, Tao ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

5 aza dC; DNA methylation; hTERT; telomerase; telomere length

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; BISULFITE; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE; DNA BINDING PROTEIN; TERT PROTEIN, HUMAN;

ARTICLE; CARCINOMA CELL LINE; CHROMOSOME SIZE; CONTROLLED STUDY; DEMETHYLATION; ENZYME ACTIVE SITE; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IN VITRO STUDY; METHYLATION; NASOPHARYNX CARCINOMA; PROTEIN EXPRESSION; RESTRICTION FRAGMENT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING; TELOMERE; TELOMERE HOMEOSTASIS; TELOMERIC REPEAT AMPLIFICATION PROTOCOL; CPG ISLAND; DNA METHYLATION; DOWN REGULATION; GENETICS; NASOPHARYNX TUMOR; PROMOTER REGION; TUMOR CELL LINE;

CELL LINE, TUMOR; CPG ISLANDS; DNA METHYLATION; DNA-BINDING PROTEINS; DOWN-REGULATION; HUMANS; NASOPHARYNGEAL NEOPLASMS; PROMOTER REGIONS, GENETIC; TELOMERASE; TELOMERE;

EID: 84907008621     PISSN: 10849785     EISSN: 15578852     Source Type: Journal    
DOI: 10.1089/cbr.2013.1581     Document Type: Article

References (37)

1. Teixeira MT, Arneric M, Sperisen P, et al. Telomere length homeostasis is achieved via a switch between telomeraseextendible and-nonextendible states. Cell 2004;117:323.
2. Hastie ND, Dempster M, Dunlop MG, et al. Telomere reduction in human colorectal carcinoma and with ageing. Nature 1990;346:86.
3. Levy MZ, Allsopp RC, Futcher AB, et al. Telomere endreplication problem and cell aging. J Mol Biol 1992;225: 951.
4. Cech TR. Beginning to understand the end of the chromosome. Cell 2004;116:273.
5. Vera E, Canela A, Fraga MF, et al. Epigenetic regulation of telomeres in human cancer. Oncogene 2008;27:6817.
6. Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994;266:2011.
7. Shay JW, Wright WE. Telomerase therapeutics for cancer: Challenges and new directions. Nat Rev Drug Discov 2006; 5:577.
8. Steinert S, Shay JW, Wright WE. Modification of subtelomeric DNA. Mol Cell Biol 2004;24:4571.
9. Blasco MA. The epigenetic regulation of mammalian telomeres. Nat Rev Genet 2007;8:299.
10. Kyo S, Takakura M, Fujiwara T, et al. Understanding and exploiting hTERT promoter regulation for diagnosis and treatment of human cancers. Cancer Sci 2008;99:1528.
11. Liu L, Lai S, Andrews LG, et al. Genetic and epigenetic modulation of telomerase activity in development and disease. Gene 2004;340:1.
12. Lopatina NG, Poole JC, Saldanha SN, et al. Control mechanisms in the regulation of telomerase reverse transcriptase expression in differentiating human teratocarcinoma cells. Biochem Biophys Res Commun 2003;306:650.
13. Kikuno N, Shiina H, Urakami S, et al. Genistein mediated histone acetylation and demethylation activates tumor suppressor genes in prostate cancer cells. Int J Cancer 2008; 123:552.
14. Meeran SM, Patel SN, Tollefsbol TO. Sulforaphane causes epigenetic repression of hTERT expression in human breast cancer cell lines. PLoS One 2010;5:e11457.
15. Dessain SK, Yu H, Reddel RR, et al. Methylation of the human telomerase gene CpG island. Cancer Res 2000; 60:537.
16. Pettigrew KA, Armstrong RN, Colyer HA, et al. Differential TERT promoter methylation and response to 5-aza-2'-deoxycytidine in acute myeloid leukemia cell lines: TERT expression, telomerase activity, telomere length, and cell death. Genes Chromosomes Cancer 2012;51:768.
17. Liu L, Saldanha SN, Pate MS, et al. Epigenetic regulation of human telomerase reverse transcriptase promoter activity during cellular differentiation. Genes Chromosomes Cancer 2004;41:26.
18. Hutajulu SH, Indrasari SR, Indrawati LP, et al. Epigenetic markers for early detection of nasopharyngeal carcinoma in a high risk population. Mol Cancer 2011;10:48.
19. Chang ET, Adami HO. The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev 2006;15:1765.
20. Ho JH. An epidemiologic and clinical study of nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 1978;4: 182.
21. Lee WM, Foo W, Mang O, et al. Changing epidemiology of nasopharyngeal carcinoma in Hong Kong over a 20-year period (1980-99): An encouraging reduction in both incidence and mortality. Int J Cancer 2003;103: 680.
22. Lo KW, Huang DP. Genetic and epigenetic changes in nasopharyngeal carcinoma. Semin Cancer Biol 2002;12: 451.
23. Jones PA, Baylin SB. The epigenomics of cancer. Cell 2007;128:683.
24. Chou J, Lin YC, Kim J, et al. Nasopharyngeal carcinoma- review of the molecular mechanisms of tumorigenesis. Head Neck 2008;30:946.
25. Tao Q, Chan AT. Nasopharyngeal carcinoma: Molecular pathogenesis and therapeutic developments. Expert Rev Mol Med 2007;9:1.
26. Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002;3:415.
27. Enright BP, Kubota C, Yang X, et al. Epigenetic characteristics and development of embryos cloned from donor cells treated by trichostatin A or 5-aza-2'-deoxycytidine. Biol Reprod 2003;69:896.
28. Li Y, Liu L, Andrews LG, et al. Genistein depletes telomerase activity through cross-talk between genetic and epigenetic mechanisms. Int J Cancer 2009;125:286.
29. Bechter OE, Eisterer W, Dlaska M, et al. CpG island methylation of the hTERT promoter is associated with lower telomerase activity in B-cell lymphocytic leukemia. Exp Hematol 2002;30:26.
30. Guilleret I, Benhattar J. Demethylation of the human telomerase catalytic subunit (hTERT) gene promoter reduced hTERT expression and telomerase activity and shortened telomeres. Exp Cell Res 2003;289:326.
31. Takakura M, Kyo S, Kanaya T, et al. Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer cells. Cancer Res 1999;59:551.
32. Renaud S, Loukinov D, Abdullaev Z, et al. Dual role of DNA methylation inside and outside of CTCF-binding regions in the transcriptional regulation of the telomerase hTERT gene. Nucleic Acids Res 2007;35:1245.
33. Kanduri C, Pant V, Loukinov D, et al. Functional association of CTCF with the insulator upstream of the H19 gene is parent of origin-specific and methylation-sensitive. Curr Biol 2000;10:853.
34. Kumakura S, Tsutsui TW, Yagisawa J, et al. Reversible conversion of immortal human cells from telomerase-positive to telomerase-negative cells. Cancer Res 2005;65:2778.
35. Zinn RL, Pruitt K, Eguchi S, et al. HTERT is expressed in cancer cell lines despite promoter DNA methylation by preservation of unmethylated DNA and active chromatin around the transcription start site. Cancer Res 2007;67:194.
36. Feng J, Funk WD, Wang SS, et al. The RNA component of human telomerase. Science 1995;269:1236.
37. Morrish TA, Greider CW. Short telomeres initiate telomere recombination in primary and tumor cells. PLoS Genet 2009;5:e1000357.